4.5 Article

AAOS Research Symposium Updates and Consensus: Biologic Treatment of Orthopaedic Injuries

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.5435/JAAOS-D-16-00086

关键词

-

资金

  1. Arthrex
  2. Ossur
  3. Smith Nephew
  4. ConMed Linvatec
  5. Aesculap/B. Braun Medical
  6. Aperion Biologics
  7. Becton Dickinson
  8. DePuy Synthes
  9. Genzyme
  10. Moximed
  11. RNL Bio

向作者/读者索取更多资源

Strategies that seek to enhance musculoskeletal tissue regeneration and repair by modulating the biologic microenvironment at the site of injury have copsiderable therapeutic potential. Current and emerging biologic approaches include the use of growth factors, platelet-rich plasma, stem cell therapy, and scaffolds,The American Academy of Orthopaedic Surgeons hosted a research symposium in November 2015 to review the current state-of-the-art biologic treatments of articular cartilage, muscle, tendon; and bone injuries and identify knowledge gaps related to these emerging treatments This review outlines the findings of the symposium and summarizes the, consensus reached on how best to advance research on biologic treatment of orthopaedic injuries.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据